The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 29, 2026
Filed:
Jan. 24, 2022
Applicant:
Athos Therapeutics, Inc., Torrance, CA (US);
Inventors:
Dimitrios Iliopoulos, Los Angeles, CA (US);
David G. Ho, Monterey Park, CA (US);
Iordanis Karagiannidis, North Hollywood, CA (US);
Phithi Nguyen, Anaheim, CA (US);
Dimitra Chalkia, Fullerton, CA (US);
Assignee:
Athos Therapeutics, Inc., Torrance, CA (US);
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07D 207/333 (2006.01); A61K 9/00 (2006.01); A61K 9/02 (2006.01); A61K 9/20 (2006.01); A61K 9/48 (2006.01); A61K 31/401 (2006.01); A61K 31/4025 (2006.01); A61K 31/407 (2006.01); A61K 31/4439 (2006.01); A61K 31/695 (2006.01); A61K 47/02 (2006.01); A61K 47/12 (2006.01); A61K 47/14 (2017.01); A61K 47/26 (2006.01); C07D 401/06 (2006.01); C07D 403/06 (2006.01); C07D 491/107 (2006.01); C07F 7/18 (2006.01);
U.S. Cl.
CPC ...
C07D 207/333 (2013.01); A61K 9/0019 (2013.01); A61K 9/0053 (2013.01); A61K 9/02 (2013.01); A61K 9/2013 (2013.01); A61K 9/2018 (2013.01); A61K 9/2054 (2013.01); A61K 9/2059 (2013.01); A61K 9/4825 (2013.01); A61K 9/4858 (2013.01); A61K 31/401 (2013.01); A61K 31/4025 (2013.01); A61K 31/407 (2013.01); A61K 31/4439 (2013.01); A61K 31/695 (2013.01); A61K 47/02 (2013.01); A61K 47/12 (2013.01); A61K 47/14 (2013.01); A61K 47/26 (2013.01); C07D 401/06 (2013.01); C07D 403/06 (2013.01); C07D 491/107 (2013.01); C07F 7/1804 (2013.01); C07F 7/1892 (2013.01);
Abstract
Disclosed herein are compounds (e.g., pyrrole compounds, carboxy pyrroles, etc.), including pharmaceutical compositions that include one or more of such compounds (e.g., carboxy pyrroles). Also disclosed are methods of making carboxy pyrrole compounds. Also disclosed herein are methods of treating diseases and/or conditions (e.g., inflammation and/or cancer) with the carboxy pyrrole compounds disclosed herein.